Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples